A Prospective, Single-arm, Trial to Determine Contamination Rates When Using an Antibacterial Incise Drape During Orthopedic Surgery
Condition(s) studied
Investigational drug(s) / intervention(s)
3M™ Ioban™ CHG Chlorhexidine Gluconate Incise Drape (2% w/w CHG): A CHG-impregnated antimicrobial incise drape applied to the surgical site prior to incision during primary hip or knee arthroplasty.
Study summary
The goal of this clinical study is to generate data on the intended use of a chlorhexidine gluconate (CHG)-impregnated antimicrobial incise drape. The study includes subjects undergoing primary hip or knee arthroplasty procedures.
The study evaluates the intraoperative performance and safety of the incise drape during surgery, including assessment of contamination and operative characteristics.
Participants will have a CHG-impregnated antimicrobial incise drape applied during their surgical procedure. During surgery, samples will be collected from the operative site to assess potential bacterial contamination.
Eligibility
Primary outcome measure(s)
- Evaluation of the presence of contamination at the surgical site during the operative procedure. — During surgery
Assessment of contamination at the surgical site during the operative procedure.
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| Indiana University Health (IU Health) | Fishers | Indiana | Recruiting |
| University of Utah Health - Department of Orthopedics | Salt Lake City | Utah | Recruiting |
More Solventum US LLC trials in the USA
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07356323 on ClinicalTrials.gov ↗ ← All trials in the USA